dc.contributor.author
Kocatürk, Emek
dc.contributor.author
Muñoz, Melba
dc.contributor.author
Elieh-Ali-Komi, Daniel
dc.contributor.author
Criado, Paulo Ricardo
dc.contributor.author
Peter, Jonny
dc.contributor.author
Kolkhir, Pavel
dc.contributor.author
Can, Pelin
dc.contributor.author
Wedi, Bettina
dc.contributor.author
Rudenko, Michael
dc.contributor.author
Gotua, Maia
dc.contributor.author
Ensina, Luis Felipe
dc.contributor.author
Grattan, Clive
dc.contributor.author
Maurer, Marcus
dc.date.accessioned
2024-07-12T10:22:35Z
dc.date.available
2024-07-12T10:22:35Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/44216
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-43926
dc.description.abstract
Since more than a century ago, there has been awareness of the connection between viral infections and the onset and exacerbation of urticaria. Our knowledge about the role of viral infection and vaccination in acute and chronic urticaria improved as a result of the COVID-19 pandemic but it has also highlighted knowledge gaps. Viral infections, especially respiratory tract infections like COVID-19, can trigger the onset of acute urticaria (AU) and the exacerbation of chronic urticaria (CU). Less frequently, vaccination against viruses including SARS-CoV-2 can also lead to new onset urticaria as well as worsening of CU in minority. Here, with a particular focus on COVID-19, we review what is known about the role of viral infections and vaccinations as triggers and causes of acute and chronic urticaria. We also discuss possible mechanistic pathways and outline the unmet needs in our knowledge. Although the underlying mechanisms are not clearly understood, it is believed that viral signals, medications, and stress can activate skin mast cells (MCs). Further studies are needed to fully understand the relevance of viral infections and vaccinations in acute and chronic urticaria and to better clarify causal pathways.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
viral infections
en
dc.subject
adverse events
en
dc.subject
exacerbation
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1585
dcterms.bibliographicCitation.doi
10.3390/v15071585
dcterms.bibliographicCitation.journaltitle
Viruses
dcterms.bibliographicCitation.number
7
dcterms.bibliographicCitation.originalpublishername
MDPI AG
dcterms.bibliographicCitation.volume
15
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37515272
dcterms.isPartOf.eissn
1999-4915